Literature DB >> 20708461

IMP3 expression in triple-negative breast carcinoma.

Angelo Sidoni, Fabio Cartaginese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708461     DOI: 10.1016/j.humpath.2010.05.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  6 in total

1.  Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodules.

Authors:  Sezer Kulaçoğlu; Gamze Erkılınç
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 2.  Adenoid cystic carcinoma of breast: Recent advances.

Authors:  Kosuke Miyai; Mary R Schwartz; Mukul K Divatia; Rose C Anton; Yong Wook Park; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

3.  Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese cases.

Authors:  Xiangjie Sun; Ping Wei; Chen Shen; Yusi Yang; Yiqin Wang; Yuan Li; Xiang Du
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 4.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

Authors:  Jessica L Bell; Kristin Wächter; Britta Mühleck; Nikolaos Pazaitis; Marcel Köhn; Marcell Lederer; Stefan Hüttelmaier
Journal:  Cell Mol Life Sci       Date:  2012-10-16       Impact factor: 9.261

5.  CircRNA circFOXK2 facilitates oncogenesis in breast cancer via IGF2BP3/miR-370 axis.

Authors:  Wei Zhang; Hui Liu; Junjie Jiang; Yunyun Yang; Wenjie Wang; Zhengyan Jia
Journal:  Aging (Albany NY)       Date:  2021-07-30       Impact factor: 5.682

6.  Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer.

Authors:  Nikoleta Sjekloča; Snjezana Tomić; Ivana Mrklić; Filip Vukmirović; Ljiljana Vučković; Ingrid Belas Lovasić; Marina Maras-Šimunić
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.